Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely capecitabine 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely aluminium hydroxide 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely olsalazine sodium 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely methylcellulose-450 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely methyldopa 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely alprazolam 500 microgram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely haloperidol 500 microgram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely haloperidol 500 microgram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely amoxicillin 500 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely ampicillin 500 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely cefaclor 500 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely cefadroxil 500 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely cefalexin monohydrate 500 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely cefalexin hydrochloride 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely cefradine 500 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely cefprozil 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely neomycin sulfate 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely azithromycin dihydrate 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely metronidazole 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely nalidixic acid 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely niclosamide 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely metformin hydrochloride 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely betamethasone 500 microgram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely hydroxycarbamide 500 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely mycophenolate mofetil 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely ascorbic acid 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely alfacalcidol 500 nanogram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely calcitriol 500 nanogram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely naproxen 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely nabumetone 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely cefuroxime 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely methenamine mandelate 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely methenamine mandelate 300 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
2 |
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
2 |
Product containing precisely mitotane 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely chloroquine phosphate 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely anagrelide hydrochloride 500 microgram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely amoxicillin 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely methocarbamol 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely ampicillin trihydrate 500 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely bumetanide 500 microgram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely aminocaproic acid 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely benzatropine mesilate 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely cefuroxime axetil 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely chlorothiazide 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely nicotinic acid 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely aspirin 500 milligram and hydrocodone bitartrate 5 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
2 |
Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
2 |
Product containing precisely lovastatin 20 milligram and nicotinic acid 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely acetohexamide 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely oxacillin sodium 500 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely nabilone 500 microgram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely nitazoxanide 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 2 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
2 |
Product containing precisely metformin hydrochloride 500 milligram and repaglinide 1 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
2 |
Product containing precisely bosutinib monohydrate 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely sodium bicarbonate 500 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely sulfasalazine 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely prazosin (as prazosin hydrochloride) 500 microgram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely trandolapril 500 microgram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely inositol niacinate 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely tranexamic acid 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely lormetazepam 500 microgram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely tryptophan 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely paracetamol 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely methionine 100 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
2 |
Product containing precisely paracetamol 500 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely methionine 250 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
2 |
Product containing precisely dihydrocodeine tartrate 20 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely codeine phosphate 13.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
2 |
Product containing precisely domperidone (as domperidone maleate) 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely metoclopramide 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely pizotifen 500 microgram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely vigabatrin 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely levetiracetam 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely levodopa 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely amoxicillin 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
2 |
Product containing precisely sulfadiazine 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely sulfaguanidine 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely pyrazinamide 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely tinidazole 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely levofloxacin 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely inosine pranobex 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely valaciclovir (as valaciclovir hydrochloride) 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely tolbutamide 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely repaglinide 500 microgram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely tacrolimus 500 microgram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely medroxyprogesterone acetate 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely potassium aminobenzoate 500 milligram/1 each conventional release oral capsule |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely potassium aminobenzoate 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely sodium phenylbutyrate 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely mefenamic acid 500 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |
Product containing precisely sulfasalazine 500 milligram/1 each gastro-resistant oral tablet |
Has presentation strength numerator value |
False |
500 |
Inferred relationship |
Existential restriction modifier |
1 |